Foster City, CA, United States of America

Deborah S Winetzky

USPTO Granted Patents = 11 



Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 83(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2002)
  • Foster City, CA (US) (1999 - 2015)

Company Filing History:


Years Active: 1999-2015

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Deborah S Winetzky

Introduction

Deborah S Winetzky is a prominent inventor based in Foster City, CA (US). She has made significant contributions to the field of peptide technology, holding a total of 11 patents. Her work focuses on methods for selective targeting, particularly in relation to skin and hair.

Latest Patents

One of her latest patents involves a selective targeting method that includes contacting a peptide library with an anti-target to facilitate binding. This process allows for the separation of non-binding peptides from those that are bound to the anti-target. The method further involves contacting the non-binding anti-target peptides with a target, enabling the formation of a target-bound peptide complex. In this context, the target can be skin or hair, with the anti-target being the opposite. Another notable patent is directed towards peptides that specifically bind to skin without binding to hair, and vice versa.

Career Highlights

Throughout her career, Deborah has worked with notable companies such as Genencor International, Inc. and Danisco US Inc. Her expertise in peptide technology has positioned her as a leader in her field, contributing to advancements that have practical applications in various industries.

Collaborations

Deborah has collaborated with esteemed colleagues, including Giselle G Janssen and Christopher James Murray. These partnerships have further enriched her research and development efforts.

Conclusion

Deborah S Winetzky's innovative work in peptide technology and her impressive portfolio of patents underscore her significant impact in the field. Her contributions continue to pave the way for advancements in targeted therapies and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…